IP Library Granted Patent US 7,655,146
Granted Patent B2
US 7,655,146 · App. 11/675,275 · Granted Feb 2, 2010

Method for filtering blood or blood components using leukocyte-removing filter and filter device

Assignee: Asahi Kasei Medical Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,655,146
App. No.
11/675,275
Granted
Feb 2, 2010
Kind
B2
Abstract

The method comprises providing a leukocyte-removing filter having a thickness of 9.0 mm to 9.4 mm, an air permeability pressure drop of 300 Pa to 700 Pa, and effective filtration area of 50 cm 2 to 70 cm 2 which comprises a flat and flexible container having an inlet port and an outlet port and a sheet-like leukocyte-removing-filter material with a thickness of 8.2 mm to 8.6 mm disposed to divide the container into an inlet-port side chamber and an outlet-port side chamber, providing a pair of volume restriction boards disposed outside of the inlet port side external surface and the outlet port side external surface of the flexible container, having the distance between the volume restriction boards at the portion where the volume restriction boards facing each other sandwich the leukocyte-removing filter being in a range from [thickness of leukocyte-removing filter+0.5 mm] to [thickness of leukocyte-removing filter+2.5 mm], and filtering blood or blood components through the leukocyte-removing filter under a pressure of 30 kPa to 50 kPa while restraining expansion of the flexible container occurring during filtration by means of the volume restriction boards.

Claims (12)

1. A method for filtering blood or blood components, comprising providing a leukocyte-removing filter having a thickness of 9.0 mm to 9.4 mm, an air permeability pressure drop of 300 Pa to 700 Pa and effective filtration area of 50 cm 2 to 70 cm 2 which comprises a flat and flexible container having an inlet port and an outlet port and a sheet-like leukocyte-removing-filter material with a thickness of 8.2 mm to 8.6 mm disposed to divide the container into an inlet-port side chamber and an outlet-port side chamber, providing a pair of volume restriction boards disposed outside of the inlet port side external surface and the outlet port side external surface of the flexible container, having the distance between the volume restriction boards at the portion where the volume restriction boards facing each other sandwich the leukocyte-removing filter being in a range from [thickness of leukocyte-removing filter+0.5 mm] to [thickness of leukocyte-removing filter+2.5 mm], and filtering blood or blood components through the leukocyte-removing filter under a pressure of 30 kPa to 50 kPa while restraining the expansion of the flexible container occurring during filtration by means of the volume restriction boards.

2. The method according to claim 1 , wherein the viscosity of blood or blood components is 5 mPa·s to 15 mPa·s.

3. The method according to claim 1 , wherein the blood or blood components are a concentrated erythrocyte product.

4. The method according to claim 1 , wherein the flat and flexible container has Young's modulus of 7 N/mm 2 to 13 N/mm 2 and a thickness of 0.2 mm to 0.6 mm.

5. The method according to claim 1 , wherein the center of the inlet port and the center of the outlet port provided in the flat and flexible container are located on an intersection of a plane which is perpendicular to the filter material and passes through the center of the filter material, and the inlet-port side external surface or the outlet-port side external surface, the straight line which connects the center of the inlet-port and the center of the outlet-port passes through the center of the filter material, and the center of the inlet-port and the center of the outlet-port are respectively 10 mm to 15 mm apart from the center of the filter material.

6. The method according to claim 1 , wherein the volume restriction boards cover 80% to 100% of the effective filtration area of the leukocyte-removing filter.

7. A device for filtering blood or blood components, comprising (a) a leukocyte-removing filter having a thickness of 9.0 mm to 9.4 mm, an air permeability pressure drop of 300 Pa to 700 Pa, and effective filtration area of 50 cm 2 to 70 cm 2 which comprises a flat and flexible container having an inlet port and an outlet port and a sheet-like leukocyte-removing-filter material with a thickness of 8.2 mm to 8.6 mm disposed to divide the container into an inlet-port side chamber and an outlet-port side chamber, and (b) a pair of volume restriction boards disposed outside of the inlet port side external surface and the outlet port side external surface of the flexible container, having the distance between the volume restriction boards at the portion where the volume restriction boards facing each other sandwich the leukocyte-removing filter being in a range from [thickness of leukocyte-removing filter+0.5 mm] to [thickness of leukocyte-removing filter+2.5 mm].

8. The device according to claim 7 , wherein the flat and flexible container has Young's modulus of 7 N/mm 2 to 13 N/mm 2 and a thickness of 0.2 mm to 0.6 mm.

9. The device according to claim 7 , wherein the center of the inlet port and the center of the outlet port provided in the flat and flexible container are located on an intersection of a plane which is perpendicular to the filter material and passes through the center of the filter material, and the inlet-port side external surface or the outlet-port side external surface, the straight line which connects the center of the inlet-port and the center of the outlet-port passes through the center of the filter material, and the center of the inlet-port and the center of the outlet-port are respectively 10 mm to 15 mm apart from the center of the filter material.

10. The device according to claim 7 , wherein the volume restriction boards cover 80% to 100% of the effective filtration area of the leukocyte-removing filter.

11. The device according to claim 7 , wherein a pair of the volume restriction boards is an integral structure with a U-shaped cross-sectional configuration.

12. The device according to claim 7 , wherein a pair of the volume restriction boards is formed from two separate plates bonded in a secured or semi-secured state to maintain a certain space between them.

Assignments (4)
NUNC PRO TUNC ASSIGNMENT Recorded Oct 23, 2025
From: ASAHI KASEI MEDICAL CO., LTD.
To: ASAHI KASEI LIFE SCIENCE CORPORATION
Reel/Frame 072650/0232 →
CHANGE OF ADDRESS Recorded Oct 23, 2025
From: ASAHI KASEI MEDICAL CO., LTD.
To: ASAHI KASEI MEDICAL CO., LTD.
Reel/Frame 073190/0942 →
CHANGE OF ADDRESS Recorded Oct 23, 2025
From: ASAHI KASEI MEDICAL CO., LTD.
To: ASAHI KASEI MEDICAL CO., LTD.
Reel/Frame 073190/0981 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2007
From: OZEKI, MAKOTO; YAJIMA, KENTARO
To: ASAHI KASEI MEDICAL CO., LTD.
Reel/Frame 019281/0050 →
Priority Claims (1)
JP 2006-042225 · Feb 20, 2006 · national
Continuity (1)
Related Publication 20070199897A1 · Aug 30, 2007